Abstract:Background: As one of the most common body malignant cancers, skin cancers contain a group of highly heterogeneous tumors with different malignant potential, prognosis and treatment methods. Despite the progress in the treatment of skin cancers worldwide, the overall prognosis is still poor. Recent studies indicated single nucleotide polymorphisms (SNPs) of interleukin-6 (IL-6), including 174G/C and 597G/A, might be associated with susceptibility to skin cancer. This meta-analysis aims to clarify the relationship between IL-6 gene polymorphisms and skin cancers. Methods: Eligible studies were identified from searching PubMed, Embase, Web of Science and Cochrane. Pooled odds ratio (OR) and corresponding 95% confidence interval (CI) were obtained for the relationships between IL-6 174G/C and 597G/A polymorphisms and skin cancer using random-effects models. For the included studies, the Newcastle-Ottawa scale (NOS) score was calculated to assess study quality. Heterogeneity tests, sensitivity analysis, and publication bias assessments were also performed. Trim-and-fill method was used when publication bias existed aiming to adjusting OR. All data were analyzed in R (version 4.0.2). Results: This meta-analysis included 1,705 cases and 1,987 controls for 174G/C polymorphism (10 publications), and 968 cases and 998 controls for 597G/A polymorphism (3 publications). No elevated risk of skin cancer was found in all comparisons for 174G/C polymorphism: CC vs. GC + GG, OR =1.03 (95% CI: 0.81-1.31); GC + CC vs. GG, OR =1.16 (95% CI: 0.96-1.39); CC vs. GG, OR =1.14 (95% CI: 0.86-1.53); GC vs. GG, OR =1.16 (95% CI: 0.99-1.37); C vs. G, OR =1.07 (95% CI: 0.92-1.24). Then we performed subgroup analysis based on publication year, the cancer type, sample size, NOS score. Significant differences were observed in the subgroup of publication year before 2010 (GC + CC vs. GG, OR =1.255, P=0.012; GC vs. GG, OR =1.277, P=0.01), while there is no statistical significance in the subgroup of publication year after 2010 (P>0.05 for all comparisons). After publication bias adjustment, the results further suggested that 174G/C polymorphism is not associated with the risk of skin cancer. No elevated risk of skin cancer was found in the comparisons for 597G/A polymorphism. Discussion: Current evidence showed that IL-6 gene polymorphisms might not be associated with the susceptibility to skin cancer.

Association of the Interleukin-4Rα Rs1801275 and Rs1805015 Polymorphisms with Glioma Risk

Association Between the LINC00673 Rs11655237 C> T Polymorphisms with Cancer Risk in the Chinese Population: A Meta-Analysis

Correlation of Interleukin-10-1082G/A Single Nucleotide Polymorphism to the Susceptibility of Bladder Cancer

Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants

Association Between Polymorphisms in Interleukin-4Rα and Interleukin-13 and Glioma Risk: a Meta-Analysis.

Effect of Polymorphism on IL1A to Cancer Susceptibility: Evidence Based on 34,016 Subjects

Distinct effects of rs895819 on risk of different cancers: an update meta-analysis.

Association between XRCC3 T241M polymorphism and glioma risk: a meta-analysis

IL-8 –251A/T Polymorphism is Associated with Decreased Cancer Risk among Population-Based Studies: Evidence from a Meta-Analysis

Single Nucleotide Polymorphisms in IL-4Ra IL-13 and STAT6 Genes Occurs in Brain Glioma

miR-499 rs3746444 and miR-196a-2 rs11614913 Are Associated with the Risk of Glioma, but Not the Prognosis

Impact of Single Nucleotide Polymorphism in IL-4, IL-4R Genes and Systemic Concentration of IL-4 on the Incidence of Glioma in Iraqi Patients

Association between IL13 gene polymorphisms and susceptibility to cancer: a meta-analysis.

Association of IL-27 polymorphisms and cancer risk in Chinese population

Regulator of Telomere Elongation Helicase 1 (RTEL1) Rs6010620 Polymorphism Contribute to Increased Risk of Glioma

Association between single nucleotide polymorphisms of IL-6 and susceptibility to skin cancer: a meta-analysis and systematic review

The associations between two polymorphisms in the interleukin-10 gene promoter and breast cancer risk

Association Between Il-6-174g > C Polymorphism and Risk of Prostate Cancer: A Meta-Analysis

Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects

Genetic polymorphisms of DNA double-strand break repair pathway genes and glioma susceptibility

A Polymorphism of Microrna196a Genome Region Was Associated with Decreased Risk of Glioma in Chinese Population